Intra-Cellular Therapies, Inc.

SILVERCREST ASSET MANAGEMENT GROUP LLC

Report date

12/31/2024

Quarter

2024 Q4

Filed

2/14/2025

Shares

118,265

Value ($000)

9,877

Weight

0.1%

2020 Q4 - 2024 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2024 Q4	2/14/2025	9,877	0.1%	118,265	12/31/2024
2024 Q3	11/14/2024	8,696	0.1%	118,848	9/30/2024
2024 Q2	8/15/2024	8,189	0.1%	119,570	6/30/2024
2024 Q1	5/15/2024	2,925	0.0%	42,276	3/31/2024
2023 Q4	2/14/2024	3,995	0.0%	55,783	12/31/2023
2023 Q3	11/14/2023	4,083	0.0%	78,374	9/30/2023
2023 Q2	8/14/2023	4,967	0.0%	78,444	6/30/2023
2023 Q1	5/15/2023	3,613	0.0%	66,718	3/31/2023
2022 Q4	2/14/2023	5,211	0.0%	98,474	12/31/2022
2022 Q3	11/14/2022	4,650	0.0%	99,930	9/30/2022
2022 Q2	8/15/2022	5,846	0.0%	102,414	6/30/2022
2022 Q1	5/16/2022	6,599	0.0%	107,838	3/31/2022
2021 Q4	2/14/2022	5,577	0.0%	106,559	12/31/2021
2021 Q3	11/15/2021	6,237	0.0%	167,311	9/30/2021
2021 Q2	8/16/2021	6,939	0.0%	169,994	6/30/2021
2021 Q1	5/17/2021	5,779	0.0%	170,333	3/31/2021
2020 Q4	2/16/2021	6,101	0.0%	191,850	12/31/2020